Megha Sinha, founder and CEO of Kamet Consulting Group explains why the systems most manufacturers use to manage post-approval changes are no longer fit for purpose, and what a viable alternative looks like in the AI age.
Click on the "Follow" button below and you'll get the latest news from News, opinion, and analysis for the Pharmaceutical and Drug Manufacturing Industry via email, mobile or you can read them on your personal news page on this site.
You can unsubscribe anytime you want easily.
You can also choose the topics or keywords that you're interested in, so you receive only what you want.
News, opinion, and analysis for the Pharmaceutical and Drug Manufacturing Industry title: News, opinion, and analysis for the Pharmaceutical and Drug Manufacturing Industry - European Pharmaceutical Manufacturer